BMX-001
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for BMX-001, covering 2023-03-15 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer [Phase 2]